Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Solution structure of the epidermal growth factor-like domain of heregulin-alpha, a ligand for p180erbB-4.

Nagata K, Kohda D, Hatanaka H, Ichikawa S, Matsuda S, Yamamoto T, Suzuki A, Inagaki F.

EMBO J. 1994 Aug 1;13(15):3517-23.

2.

Structure-function relationships for the EGF/TGF-alpha family of mitogens.

Groenen LC, Nice EC, Burgess AW.

Growth Factors. 1994;11(4):235-57. Review.

PMID:
7779404
3.

The solution structures of epidermal growth factor and transforming growth factor alpha.

Campbell ID, Cooke RM, Baron M, Harvey TS, Tappin MJ.

Prog Growth Factor Res. 1989;1(1):13-22. Review.

PMID:
2491252
4.

Transforming growth factor alpha.

Kumar V, Bustin SA, McKay IA.

Cell Biol Int. 1995 May;19(5):373-88. Review.

PMID:
7640654
5.

Structural basis for epidermal growth factor receptor function.

Hsuan JJ, Panayotou G, Waterfield MD.

Prog Growth Factor Res. 1989;1(1):23-32. Review.

PMID:
2491253
6.

Growth factor receptors: structure, mechanism, and drug discovery.

McInnes C, Sykes BD.

Biopolymers. 1997;43(5):339-66. Review.

PMID:
9566117
7.

The EGF domain: requirements for binding to receptors of the ErbB family.

Van Zoelen EJ, Stortelers C, Lenferink AE, Van de Poll ML.

Vitam Horm. 2000;59:99-131. Review.

PMID:
10714238
8.

Cellular and viral ligands that interact with the EGF receptor.

Todaro GJ, Rose TM, Spooner CE, Shoyab M, Plowman GD.

Semin Cancer Biol. 1990 Aug;1(4):257-63. Review.

PMID:
2103500
9.

Epidermal growth factor-related peptides in the pathogenesis of human breast cancer.

Normanno N, Ciardiello F, Brandt R, Salomon DS.

Breast Cancer Res Treat. 1994 Jan;29(1):11-27. Review.

PMID:
7912564
10.

Rational design for the development of epidermal growth factor receptor antagonists.

van Zoelen EJ, Lenferink AE, Kramer RH, van de Poll ML.

Pathol Res Pract. 1996 Jul;192(7):761-7. Review.

PMID:
8880877

Supplemental Content

Support Center